Manage cookies
We use cookies to provide the best site experience.
Accept All
Cookie Settings
Manage cookies
Cookie Settings
Cookies necessary for the correct operation of the site are always enabled.
Other cookies are configurable.
Essential cookies
Always On. These cookies are essential so that you can use the website and use its functions. They cannot be turned off. They're set in response to requests made by you, such as setting your privacy preferences, logging in or filling in forms.
Analytics cookies
Disabled
These cookies collect information to help us understand how our Websites are being used or how effective our marketing campaigns are, or to help us customise our Websites for you. See a list of the analytics cookies we use here.
Advertising cookies
Disabled
These cookies provide advertising companies with information about your online activity to help them deliver more relevant online advertising to you or to limit how many times you see an ad. This information may be shared with other advertising companies. See a list of the advertising cookies we use here.
Home
Agenda
Speakers
Partners
More
Registration & prices
Venue
News
Past events
Contacts
Register now
RU
KZ
Key Topics 2026
Key Topics 2026
Key Topics 2026
Key Topics 2026
Key Topics 2026
Key Topics 2026
Pre-Forum Day, January 26
19:00
19:00
Welcome Reception & Networking
Day 1
January 27
Day 2
January 28
Day 1
January 27
Day 2
January 28
Day 1, January 27
08:00 – 09:00
08:00 – 09:00
Participant Registration.
Morning Coffee & Networking
09:00 – 09:10
09:00 – 09:10
Forum Opening.
Welcome Address by Organizers
09:10 – 10:10
09:10 – 10:10
Plenary Discussion:
Eurasian Pharma Market – Industry Perspectives on Challenges and Opportunities
EAEU pharma market: Growth, barriers, and prospects
Production localization: Incentives, challenges, success stories
Impact of regulatory requirements on business strategies
Liberalization of public procurement: New opportunities for business
Implementation of e-document flow and product marking
Moderator:
VYACHESLAV LOKSHIN
President, Association of International Pharmaceutical Manufacturers in the Republic of Kazakhstan
10:10 – 10:30
10:10 – 10:30
Coffee Break & Networking
10:30 – 11:50
10:30 – 11:50
Plenary Session:
State and Business – Creating Conditions for Industry Growth
Legislative updates: New registration rules, GMP inspections, clinical trials
Harmonization of EAEU requirements: Progress and next steps
Support for localization and innovation: Government incentives
Plans to improve the pharmaceutical investment climate
Medicine supply in CIS countries: Draft model law discussion
11:50 – 12:10
11:50 – 12:10
Coffee Break & Networking
12:10 – 13:30
12:10 – 13:30
Panel Session:
The Future of Drug Registration in the Eurasian Region
Progress in unifying EAEU registration rules
Uzbekistan’s experience: Steps toward EAEU alignment
How unified standards reduce registration timelines
Key remaining regulatory barriers
Fast-track procedures for innovative and orphan drugs
EAEU pharmacopoeia standards: Recent changes and quality impact
Implications for API supply chains
Harmonized procedures and market entry simplification
13:30 – 13:50
13:30 – 13:50
Coffee Break & Networking
13:50 – 15:00
13:50 – 15:00
Panel Session:
Pricing and Economic Efficiency in Pharma
Comparative pricing models in EAEU/CIS: Fixed prices, tenders, reference pricing
Funding mechanisms for high-cost therapies in EAEU
Reference country selection challenges
Feasibility of unified registration/pricing in the Union
National regulation vs. deregulation: Harmonizing approaches
Balancing patient, state, and business interests
HTA impact: How efficacy assessments shape procurement
Medicine procurement: Supply chain management
15:00 – 15:40
15:00 – 15:40
Lunch Break
15:40 – 16:50
15:40 – 16:50
Panel Session:
Modern IP Protection & Management in Pharma
Generic launch strategies pre-patent expiry
Clinical/preclinical data protection: Country-specific nuances
"Insufficient use of invention" criteria in litigation
Compulsory licensing practices in EAEU
Patenting innovative drugs: Key considerations
Eurasian Pharmaceutical Register operations
Data exclusivity: Global vs. local practices
Parallel imports: Risks and opportunities
Counterfeits and copycats
16:50 – 17:10
16:50 – 17:10
Coffee Break & Networking
17:10 – 18:10
17:10 – 18:10
Real-World Data (RWD) in Pharma: From Collection to Decision-Making
Regulatory requirements for RWD collection/analysis
Leveraging RWD for early market access
Data sources: EHRs, patient registries, wearables, social media
AI and big data in RWD processing
Personalized medicine: Data-driven therapy selection
Challenges: Data quality, privacy, regulatory constraints
18:10
18:10
Day 1 Closing. Evening Reception & Informal Networking
Day 2, January 28
08:30 – 09:00
08:30 – 09:00
Morning Coffee & Networking
09:00 – 10:20
09:00 – 10:20
Expert Analytical Panel
Latest sales volumes, growth rates, and market share breakdowns (generics, innovative drugs, OTC, biologics) in EAEU countries and Uzbekistan
2026 forecasts: Which markets will show the highest growth?
Comparison with global trends: How does the EAEU perform against other regions?
Which drug categories lead in demand growth?
Impact of inflation, exchange rate fluctuations, and budget constraints on the market
Transformation of consumer preferences: New pharmaceutical demand trends in the EAEU
Key challenges and opportunities for pharma businesses in the region
How will the pharmaceutical landscape evolve in 10 years? Promising developments and new drugs
10:20 – 10:40
10:20 – 10:40
Coffee Break & Networking
10:40 – 12:00
10:40 – 12:00
Panel Session:
National Pharmaceutical R&D Projects – Integrating Science, Production, and International Partnerships
R&D: The search for new molecules
Government support priorities: Public procurement, simplified product certification
Funding mechanisms and support for scientific research
Collaboration between government institutions, businesses, and academia
Successful examples of joint projects with international partners
Creating conditions to retain highly qualified professionals in the industry
National drug security: Strategies for resilience and self-sufficiency
Accelerating the scaling of lab technologies to GMP production
Localization of biopharmaceutical production
12:00 – 12:20
12:00 – 12:20
Coffee Break & Networking
12:20 - 13:50
12:20 - 13:50
Panel Session:
Commercialization of Pharmaceutical Products – Marketing & Digital Technologies
Integrating online and offline channels to enhance customer engagement
Leveraging Big Data, analytics, and AI for personalized communications
Content marketing, social media, mobile apps, and e-commerce
Restrictions on drug advertising and consumer communications
Personalized engagement with doctors and pharmacies
Sales automation via CRM and medical representative platforms
Compliance with data protection laws when handling patient data
13:50 - 14:30
13:50 - 14:30
Lunch Break
14:30 - 15:40
14:30 - 15:40
From Factory to Patient: Optimizing Pharma Supply Chains in the New Reality
Analysis of current and future transport corridors
Use of temporary storage warehouses, cold chains, and simplified customs clearance
Practical challenges and solutions in implementing marking systems
Product marking as a tool for transparency, anti-counterfeiting, and improved customer experience
Digital platforms for order and supply management
Collaboration between manufacturers, distributors, and pharmacy networks
15:40 - 16:00
15:40 - 16:00
Coffee Break & Networking
16:00 – 17:00
16:00 – 17:00
Parallel sessions
Hall 1
How to Successfully Conduct Clinical Trials in EAEU Countries
Recent changes in EAEU and national regulatory requirements
Effective collaboration with medical institutions and research centers
AI applications for data analysis and outcome prediction
Risk and adverse event management
Best practices in communicating with healthcare facilities
GCP (Good Clinical Practice) inspections in clinical trials
Logistics in clinical research
Hall 2
Dietary Supplements Market: New Consumer Trends and Growth Opportunities
Consumption trends and consumer preferences
Classification of supplements and the fine line between food and medicinal products
Certification procedures for efficacy and safety
Combating counterfeit and unregulated products
Rising demand for immune boosters and vitamins
Online promotion of supplements within legal boundaries
Labeling requirements for dietary supplements
17:00
17:00
Discussion & Resolution Signing. Cocktail Reception
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
CONTaCT US
For any questions regarding participation, partnership, or registration, please reach out to our team:
Alexandra Dyachenko
Forum Director
A.Dyachenko@as-conf.com
+7 777 060-92-91
Kanat Zhanzak
Partner Relations Manager
k.zhanzak@as-conf.com
+7 771 766-83-93
Aizhan Nurseitova
Partner Relations Manager
a.nurseitova@as-conf.com
+7 777 197-99-07
Olga Domingues Da Cunha
For Media Partnership inquiries
O.Cunha@as-conf.com
+7 777 197-99-06
Daulet Orynbasarov
Managing Director
D.Orynbasarov@as-conf.com
+7 771 766-83-93
Adam Smith Conferences team
info@as-conf.com
+7 727 310-31-46
User Agreement
ТОО "AdamSmith Eurasia (Адам Смит Евразия)"
Use of Cookies